CFG
NVO

Citizens Financial Group’s Novo Nordisk NVO Stock Holding History

Citizens Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,997
Closed -$208K – 702
2025
Q1 		$208K Sell
2,997
-11,157
-79% -$921K ﹤0.01% 578
2024
Q4 		$1.22M Sell
14,154
-147
-1% -$15.9K 0.02% 270
2024
Q3 		$1.7M Buy
14,301
+263
+2% +$35.1K 0.03% 234
2024
Q2 		$2M Buy
14,038
+134
+1% +$17.8K 0.04% 201
2024
Q1 		$1.79M Buy
13,904
+201
+1% +$23.9K 0.06% 162
2023
Q4 		$1.42M Buy
13,703
+239
+2% +$23.6K 0.05% 188
2023
Q3 		$1.22M Buy
13,464
+10,956
+437% +$965K 0.05% 166
2023
Q2 		$203K Buy
+2,508
New +$205K 0.01% 369
2020
Q3 		– Sell
-2,400
Closed -$79K – 693
2020
Q2 		$79K Hold
2,400
– – 0.01% 396
2020
Q1 		$72K Sell
2,400
-124
-5% -$3.69K 0.01% 369
2019
Q4 		$73K Buy
2,524
+124
+5% +$3.43K ﹤0.01% 385
2019
Q3 		$62K Sell
2,400
-300
-11% -$7.59K ﹤0.01% 338
2019
Q2 		$69K Hold
2,700
– – 0.01% 333
2019
Q1 		$71K Buy
2,700
+300
+13% +$7.37K 0.01% 323
2018
Q4 		$55K Hold
2,400
– – 0.01% 289
2018
Q3 		$57K Hold
2,400
– – ﹤0.01% 312
2018
Q2 		$55K Hold
2,400
– – ﹤0.01% 304
2018
Q1 		$59K Hold
2,400
– – 0.01% 311
2017
Q4 		$64K Hold
2,400
– – 0.01% 315
2017
Q3 		$58K Hold
2,400
– – ﹤0.01% 321
2017
Q2 		$51K Hold
2,400
– – ﹤0.01% 332
2017
Q1 		$41K Hold
2,400
– – ﹤0.01% 365
2016
Q4 		$43K Hold
2,400
– – ﹤0.01% 365
2016
Q3 		$50K Sell
2,400
-1,730
-42% -$42.9K ﹤0.01% 361
2016
Q2 		$111K Hold
4,130
– – 0.01% 283
2016
Q1 		$112K Hold
4,130
– – 0.01% 282
2015
Q4 		$120K Buy
+4,130
New +$114K 0.01% 281

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Citizens Financial Group's NVO Position: Q2 2025 in Review

Citizens Financial Group sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,997 shares — an estimated $208K sold.

Citizens Financial Group first reported a position in NVO in Q4 2015 and held it in 27 quarters. The position peaked at $2M in Q2 2024. 1,484 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Citizens Financial Group reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Citizens Financial Group sold 2,997 Novo Nordisk shares in Q2 2025, an estimated $208K.
  • Citizens Financial Group first reported a position in Novo Nordisk in Q4 2015 and held it in 27 quarters.
  • Citizens Financial Group's Novo Nordisk position peaked at $2M in Q2 2024.
  • 1,484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Citizens Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.